RAN Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- RAN Biotechnologies's estimated annual revenue is currently $1.6M per year.
- RAN Biotechnologies's estimated revenue per employee is $155,000
Employee Data
- RAN Biotechnologies has 10 Employees.
- RAN Biotechnologies grew their employee count by -9% last year.
RAN Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Principal Scientist | Reveal Email/Phone |
3 | Assistant Scientist I | Reveal Email/Phone |
4 | Principal Chemist | Reveal Email/Phone |
5 | Associate scientist 2 | Reveal Email/Phone |
RAN Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is RAN Biotechnologies?
RAN Biotechnologies provides Smart Materials For Next Generation Science (TM). These include: - Gold standard FluoroSurfactants for water-in-oil emulsions and for microfluidics - Functionalized Hydrogel Beads - Chip-Free Engineered Droplet Generation kits - Affinity Chromatography resins and beads for isolation of biologicals - Affinity resins and beads and new techniques for capture, isolation and POU detection of microbes, including viruses. All our products combine: High purity; Reproducibility; Material Customization; Custom Packaging; Experienced Technical and Scientific Support.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 10 | 25% | N/A |
#2 | $1.7M | 11 | 0% | N/A |
#3 | $1.7M | 11 | 10% | N/A |
#4 | $0.9M | 11 | 57% | N/A |
#5 | $1M | 12 | -25% | N/A |